Amerigo Allegretto[email protected]ECR 2025MRI-based ML model detects leiomyosarcomasAn MRI-based machine learning (ML) model showed promise in differentiating leiomyosarcoma from atypical benign leiomyoma.March 1, 2025ECR 2025CEUS adds value to spleen trauma managementCEUS could be a suitable alternative to CT for early detection of complications in splenic trauma that’s nonoperatively managed.February 28, 2025ECR 2025Sustainability echoes throughout ECR 2025 opening ceremonySpeakers at Wednesday evening's ECR 2025 opening ceremony called on audience members to embrace better sustainability practices and collaboration.February 27, 2025ECR 2025Mammographic image quality impacts performance of AI more than radiologistsMammographic image quality affects AI performance more than radiologists, according to Dutch research presented on 27 February at ECR 2025.February 27, 2025ECR 2025Generative AI yields potential for assisting radiologistsGenerative AI may have novel applications in the clinic, but using the technology comes with its share of challenges and future directions.February 26, 2025ECR 2025Ablation suitable alternative to surgery in breast cancer treatmentImage-guided ablation techniques can be a suitable alternative to surgery for breast cancer patients.February 26, 2025MRIML model using CCTA, MRI data predicts MACE in cardiac patientsA machine-learning (ML) model that includes both CCTA and stress cardiac MRI data can accurately predict major adverse cardiovascular events (MACE).January 20, 2025MRIGenetic testing, risk assessment tied to more breast MRI uptakeWomen with high-risk pathological variants for breast cancer as identified by genetic testing and risk assessment are more likely to undergo breast MRI.January 15, 2025Womens ImagingAI-supported mammography can be effective in real-world settingsA new cancer detection study from Germany has found that AI-supported mammography screening is safe and effective in a nationwide, real-world setting.January 13, 2025Womens ImagingStudy: Starting breast screening at 40 is cost-effectiveStarting breast cancer screening at age 40 is tied to improved patient outcomes and reduced healthcare spending on treatment, new research has found.January 8, 2025Page 1 of 8Next PageTop StoriesCTClinical demand drives innovation in CT equipment marketUncertainty looms large over the CT equipment market, but clinical needs are playing a growing role in hardware advances, writes analyst Sarah-Jane James.Digital X-RayReport highlights LLM cybersecurity threatsAdvanced VisualizationHinton admits mistake in predicting AI will replace radiologistsMRIAI reconstruction can boost sustainability in MRIMRIDMI metabolic modeling provides insight for neuro diseases
